The X300 Pro runs Android 16 out of the box, now augmented by the company's OriginOS - it's a new development this year that leaves the other software branch, FuntouchOS, in the past. Formerly, only ...
Sana Biotechnology, CAMP4 Therapeutics and Crinetics Pharmaceuticals have all used the third quarter to refocus their ...
CRISPR Therapeutics AG is rated a Buy with $1.9B cash, prudent management, and undervalued shares. Learn more about CRSP ...
At AAPS PharmSci 360 2025, Elly Zhou says digital twins helped forecast the effects of drugs on human drugs via a digital control arm.
Reached agreement with FDA on pivotal study design for TSC-101 following productive end of Phase 1 meetingData from ALLOHA™ Phase 1 heme trial to ...
(Nasdaq: MGX) (the "Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create ...
No changes in protocol recommended for LUGANO and LUCIA clinical trials –– Masked safety data continues to show no safety signals, consistent ...
Prime Medicine, Inc. ( PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease November 12, 2025 8:00 AM EST ...
Sales Revenue Up 135% over Q3 2024FORT MILL, S.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on the ...
Study reshapes view of how a common leukemia begins and could point to new therapeutic strategies targeting a common weakness.
SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing ...
Earlier this month, CRISPR Therapeutics announced positive Phase 1 data for its investigational in vivo CRISPR/Cas9 therapy CTX310, which showed substantial and durable reductions in key lipid levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback